BioCentury
ARTICLE | Financial News

Vernalis banks 2.75 million

December 7, 2000 8:00 AM UTC

Vernalis (LSE:VER) divested its holding in Cancer Research Ventures (London, U.K.), the licensing and technology subsidiary of Cancer Research Campaign Technology, in exchange for 2.75 million ($4 mil...